Hemojuvelin: The hepcidin story continues

Kidney and Blood Pressure Research

Volumn 32, Issue 2, 2009, Pages 71-76

  Malyszko, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Anemia; Bone morphogenetic protein; Chronic kidney disease; Hemojuvelin; Hepcidin; Inflammation; Iron metabolism; SMAD

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; HEMOJUVELIN; HEPCIDIN; HEPCIDIN 25; INTERLEUKIN 6; ISOPROTEIN; MATRIPTASE; MATRIPTASE 2; MESSENGER RNA; PROHEPCIDIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HEMOJUVELIN; RECOMBINANT PROTEIN; SMAD PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CARDIAC PATIENT; CHRONIC KIDNEY DISEASE; CYTOKINE RELEASE; DISEASE MODEL; DOWN REGULATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE MUTATION; HEART; HEART FAILURE; HEMOCHROMATOSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; KIDNEY DISEASE; LIVER; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; HEMOCHROMATOSIS; HUMANS; INFLAMMATION MEDIATORS; IRON; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION;

EID: 61849140592     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000208988     Document Type: Review

References (45)

1. Silvestri L, Pagani A, Fazi C, Gerardi G, Levi S, Arosio P, Camaschella C: Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 2007; 109: 4503-4510.
2. Latunde-Dada GO, McKie AT, Simpson RJ: Animal models with enhanced erythropoi- esis and iron absorption. Biochim Biophys Acta 2006;1762:414-423.
3. Lanzara C, Roetto A, Daraio F, Rivard S, Fi- carella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo AP, Gram- matico P, Volinia S, Gasparini P, Camaschella C: Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004;103:4317-4321.
4. Lin L, Goldberg YP, Ganz T: Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 2005; 106:2884-2889.
5. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC: A mouse model of juvenile hemochromatosis. J Clin Invest 2005; 115:2187-2191.
6. Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD: Identification of a novel mutation (C321X) in HJV. Blood 2004; 104:2176-2177.
7. Niederkofler V, Salie R, Arber S: Hemojuve- lin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005;115:2180-2186.
8. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP: Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemo-chromatosis. Nat Genet 2004; 3: 77-82.
9. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E: Hepcidin in iron overload disorders. Blood 2005; 105: 4103-4105.
10. Rodriguez Martinez A, Niemela O, Parkkila S: Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin.Haematologica 2004; 89: 1441-1445.
11. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006; 38:531-539.
12. Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zer- fas P, Cooperman S, Eckhaus M, Rouault T, Mishra L, Deng CX: A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005; 2:399-409.
13. Truksa J, Peng H, Lee P, Beutler E: Bone mor- phogenetic proteins 2, 4, and 9 stimulate mu- rine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci USA 2006; 103:10289-10293.
14. Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY: Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008; 111: 5195-5204.
15. Kuns-Hashimoto R, Kuninger D, Nili M, Rotwein P: Selective binding of RGMc/he- mojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin. Am J Physiol 2008; 294:C994-C1003.
16. Silvestri L, Pagani A, Camaschella C: Furin- mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeo-stasis. Blood 2008; 111: 924-931.
17. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY: Modulation of bone morphoge- netic protein signaling in vivo regulates systemic iron balance. J Clin Invest 2007;117: 1933-1939.
18. Anderson GJ, Darshan D, Wilkins SJ, Frazer DM: Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals 2007; 20:665-674.
19. Stremmel W: Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 2005; 72: 22-24.
20. Dunn LL, Rahmanto YS, Richardson DR: Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007;17:93-100.
21. Mok H, Mlodnicka AE, Hentze MW, Muckenthaler M, Schumacher A: The molecular circuitry regulating the switch between iron deficiency and overload in mice. J Biol Chem 2006;281: 7946-7951.
22. Steele TM, Frazer DM, Anderson GJ: Systemic regulation of intestinal iron absorption. IUBMB Life 2005; 57: 499-503.
23. Lee P, Peng H, Gelbart T, Wang L, Beutler E: Regulation of hepcidin transcription by in- terleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005; 102: 1906-1910.
24. Lou DQ, Lesbordes JC, Nicolas G, Viatte L, Bennoun M, Van Rooijen N, Kahn A, Renia L, Vaulont S: Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepa- tology 2005;41:1056-1064.
25. Theurl I, Ludwiczek S, Eller P, Seifert M, Artner E, Brunner P, Weiss G: Pathways for the regulation of body iron homeostasis in response to experimental iron overload. J Hepatol 2005;43:711-719.
26. Gleeson F, Ryan E, Barrett S, Russell J, Crowe J: Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis. Blood Cells Mol Dis 2007; 38: 37-44.
27. Ludwiczek S, Theurl I, Bahram S, Schumann K, Weiss G: Regulatory networks for the control of body iron homeostasis and their dys- regulation in HFE-mediated hemochroma- tosis. J Cell Physiol 2005;204:489-499.
28. Krijt J, Vokurka M, Chang KT, Necas E: Expression of RGMc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 2004; 104: 4308-4310.
29. Gehrke SG, Herrmann T, Kulaksiz H, Merle U, Bents K, Kaiser I, Riedel HD: Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 2005; 72: 25-32.
30. Vokurka M, Krijt J, Sulc K, Necas E: Hepci- din mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006;55:667-674.
31. Celec P: Hemojuvelin: a supposed role in iron metabolism one year after its discovery. J Mol Med 2005;83:521-525.
32. Constante M, Wang D, Raymond VA, Bi- lodeau M, Santos MM: Repression of repulsive guidance molecule C during inflammation is independent of hfe and involves tumor necrosis factor-aα. Am J Pathol 2007; 170:497-504.
33. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113: 1271-1276.
34. Christiansen H, Sheikh N, Saile B, Reuter F, Rave-Frank M, Hermann RM, Dudas J, Hille A, Hess CF, Ramadori G: X-irradiation in rat liver: consequent upregulation of hepcidin and downregulation of hemojuvelin and fer- roportin-1 gene expression. Radiology 2007; 242:189-197.
35. Tomosugi N, Kawabata H, Wakatabe R, Hi- guchi M, Yamaya H, Umehara H, Ishikawa I: Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 2006;108:1381-1387.
36. Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A: Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol 2008;28:115-121.
37. Ganz T, Olbina G, Girelli D, Nemeth E, Wes- terman M: Immunoassay for human serum hepcidin. Blood 2008;112:4292-4297.
38. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, Khovananth K, Mudd S, Mann N, Mores- co EM, Beutler E, Beutler B: The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008; 320: 1088-1092.
39. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, et al: Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia. Nat Genet 2008;40:569-571.
40. Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, et al: A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008; 93: 1473-1479.
41. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C: The serine protease matriptase-2 (TMPRSS6) inhibits hepci- din activation by cleaving membrane hemo-juvelin. Cell Metab 2008; 8: 502-511.
42. Toblli JE, Cao G, Rivas C, Kulaksiz H: Heart and iron deficiency anaemia in rats with renal insufficiency: the role of hepcidin. Ne- phrology (Carlton) 2008;13:636-645.
43. Malyszko J, Malyszko JS, Pawlak K, Droz- dowska-Rams L, Brzosko S, Mysliwiec M: Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients. Perit Dial Int 2008;28:418-421.
44. Malyszko J, Malyszko JS, Pawlak K, Mysli- wiec M: Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J He- matol 2006;81:832-837.
45. Sheikh N, Dudas J, Ramadori G: Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat. Lab Invest 2007;87:713-725.